カテゴリー： QYResearch, 世界, 医療/バイオ

世界の好酸球性喘息治療薬市場インサイト及び予測（静脈内注入、皮下注射）

◆英語タイトル：Global Medicines for Eosinophilic Asthma Treatment Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX10405）◆商品コード：QY22JLX10405
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：92
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、好酸球性喘息治療薬のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に好酸球性喘息治療薬の世界市場のxxx％を占める「静脈内注入」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「子供」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
好酸球性喘息治療薬の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの好酸球性喘息治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

好酸球性喘息治療薬のグローバル主要企業には、AstraZeneca、GSK、Genentech (Roche Group) & Novartis、Regeneron Pharmaceuticals & Sanofi、Teva Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

好酸球性喘息治療薬市場は、種類と用途によって区分されます。世界の好酸球性喘息治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
静脈内注入、皮下注射

【用途別セグメント】
子供、成人、青少年

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 好酸球性喘息治療薬製品概要
- 種類別市場（静脈内注入、皮下注射）
- 用途別市場（子供、成人、青少年）
- 調査の目的
・エグゼクティブサマリー
- 世界の好酸球性喘息治療薬販売量予測2017-2028
- 世界の好酸球性喘息治療薬売上予測2017-2028
- 好酸球性喘息治療薬の地域別販売量
- 好酸球性喘息治療薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別好酸球性喘息治療薬販売量
- 主要メーカー別好酸球性喘息治療薬売上
- 主要メーカー別好酸球性喘息治療薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（静脈内注入、皮下注射）
- 好酸球性喘息治療薬の種類別販売量
- 好酸球性喘息治療薬の種類別売上
- 好酸球性喘息治療薬の種類別価格
・用途別市場規模（子供、成人、青少年）
- 好酸球性喘息治療薬の用途別販売量
- 好酸球性喘息治療薬の用途別売上
- 好酸球性喘息治療薬の用途別価格
・北米市場
- 北米の好酸球性喘息治療薬市場規模（種類別、用途別）
- 主要国別の好酸球性喘息治療薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの好酸球性喘息治療薬市場規模（種類別、用途別）
- 主要国別の好酸球性喘息治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の好酸球性喘息治療薬市場規模（種類別、用途別）
- 主要国別の好酸球性喘息治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の好酸球性喘息治療薬市場規模（種類別、用途別）
- 主要国別の好酸球性喘息治療薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの好酸球性喘息治療薬市場規模（種類別、用途別）
- 主要国別の好酸球性喘息治療薬市場規模（トルコ、サウジアラビア）
・企業情報
AstraZeneca、GSK、Genentech (Roche Group) & Novartis、Regeneron Pharmaceuticals & Sanofi、Teva Pharmaceuticals
・産業チェーン及び販売チャネル分析
- 好酸球性喘息治療薬の産業チェーン分析
- 好酸球性喘息治療薬の原材料
- 好酸球性喘息治療薬の生産プロセス
- 好酸球性喘息治療薬の販売及びマーケティング
- 好酸球性喘息治療薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 好酸球性喘息治療薬の産業動向
- 好酸球性喘息治療薬のマーケットドライバー
- 好酸球性喘息治療薬の課題
- 好酸球性喘息治療薬の阻害要因
・主な調査結果

Market Analysis and Insights: Global Medicines for Eosinophilic Asthma Treatment Market
The global Medicines for Eosinophilic Asthma Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Intravenous Infusion accounting for % of the Medicines for Eosinophilic Asthma Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Children segment is altered to an % CAGR throughout this forecast period.
China Medicines for Eosinophilic Asthma Treatment market size is valued at US$ million in 2021, while the North America and Europe Medicines for Eosinophilic Asthma Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Medicines for Eosinophilic Asthma Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Medicines for Eosinophilic Asthma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Medicines for Eosinophilic Asthma Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Medicines for Eosinophilic Asthma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Medicines for Eosinophilic Asthma Treatment market.
Global Medicines for Eosinophilic Asthma Treatment Scope and Market Size
Medicines for Eosinophilic Asthma Treatment market is segmented by players, region (country), by Drug Delivery Method and by Application. Players, stakeholders, and other participants in the global Medicines for Eosinophilic Asthma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Drug Delivery Method and by Application for the period 2017-2028.
Segment by Drug Delivery Method
Intravenous Infusion
Subcutaneous Injection
Segment by Application
Children
Adults
Teenagers
By Company
AstraZeneca
GSK
Genentech (Roche Group) & Novartis
Regeneron Pharmaceuticals & Sanofi
Teva Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Drug Delivery Method
1.2.1 Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Drug Delivery Method, 2017 VS 2021 VS 2028
1.2.2 Intravenous Infusion
1.2.3 Subcutaneous Injection
1.3 Market by Application
1.3.1 Global Medicines for Eosinophilic Asthma Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adults
1.3.4 Teenagers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Medicines for Eosinophilic Asthma Treatment Market Perspective (2017-2028)
2.2 Medicines for Eosinophilic Asthma Treatment Growth Trends by Region
2.2.1 Medicines for Eosinophilic Asthma Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Medicines for Eosinophilic Asthma Treatment Historic Market Size by Region (2017-2022)
2.2.3 Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Region (2023-2028)
2.3 Medicines for Eosinophilic Asthma Treatment Market Dynamics
2.3.1 Medicines for Eosinophilic Asthma Treatment Industry Trends
2.3.2 Medicines for Eosinophilic Asthma Treatment Market Drivers
2.3.3 Medicines for Eosinophilic Asthma Treatment Market Challenges
2.3.4 Medicines for Eosinophilic Asthma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medicines for Eosinophilic Asthma Treatment Players by Revenue
3.1.1 Global Top Medicines for Eosinophilic Asthma Treatment Players by Revenue (2017-2022)
3.1.2 Global Medicines for Eosinophilic Asthma Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Medicines for Eosinophilic Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medicines for Eosinophilic Asthma Treatment Revenue
3.4 Global Medicines for Eosinophilic Asthma Treatment Market Concentration Ratio
3.4.1 Global Medicines for Eosinophilic Asthma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medicines for Eosinophilic Asthma Treatment Revenue in 2021
3.5 Medicines for Eosinophilic Asthma Treatment Key Players Head office and Area Served
3.6 Key Players Medicines for Eosinophilic Asthma Treatment Product Solution and Service
3.7 Date of Enter into Medicines for Eosinophilic Asthma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medicines for Eosinophilic Asthma Treatment Breakdown Data by Drug Delivery Method
4.1 Global Medicines for Eosinophilic Asthma Treatment Historic Market Size by Drug Delivery Method (2017-2022)
4.2 Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Drug Delivery Method (2023-2028)
5 Medicines for Eosinophilic Asthma Treatment Breakdown Data by Application
5.1 Global Medicines for Eosinophilic Asthma Treatment Historic Market Size by Application (2017-2022)
5.2 Global Medicines for Eosinophilic Asthma Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Medicines for Eosinophilic Asthma Treatment Market Size (2017-2028)
6.2 North America Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method
6.2.1 North America Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method (2017-2022)
6.2.2 North America Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method (2023-2028)
6.2.3 North America Medicines for Eosinophilic Asthma Treatment Market Share by Drug Delivery Method (2017-2028)
6.3 North America Medicines for Eosinophilic Asthma Treatment Market Size by Application
6.3.1 North America Medicines for Eosinophilic Asthma Treatment Market Size by Application (2017-2022)
6.3.2 North America Medicines for Eosinophilic Asthma Treatment Market Size by Application (2023-2028)
6.3.3 North America Medicines for Eosinophilic Asthma Treatment Market Share by Application (2017-2028)
6.4 North America Medicines for Eosinophilic Asthma Treatment Market Size by Country
6.4.1 North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2017-2022)
6.4.2 North America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Medicines for Eosinophilic Asthma Treatment Market Size (2017-2028)
7.2 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method
7.2.1 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method (2017-2022)
7.2.2 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method (2023-2028)
7.2.3 Europe Medicines for Eosinophilic Asthma Treatment Market Share by Drug Delivery Method (2017-2028)
7.3 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Application
7.3.1 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Application (2017-2022)
7.3.2 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Application (2023-2028)
7.3.3 Europe Medicines for Eosinophilic Asthma Treatment Market Share by Application (2017-2028)
7.4 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country
7.4.1 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2017-2022)
7.4.2 Europe Medicines for Eosinophilic Asthma Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size (2017-2028)
8.2 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method
8.2.1 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method (2017-2022)
8.2.2 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method (2023-2028)
8.2.3 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Share by Drug Delivery Method (2017-2028)
8.3 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Application
8.3.1 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Region
8.4.1 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Medicines for Eosinophilic Asthma Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Medicines for Eosinophilic Asthma Treatment Market Size (2017-2028)
9.2 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method
9.2.1 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method (2017-2022)
9.2.2 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method (2023-2028)
9.2.3 Latin America Medicines for Eosinophilic Asthma Treatment Market Share by Drug Delivery Method (2017-2028)
9.3 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Application
9.3.1 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Medicines for Eosinophilic Asthma Treatment Market Share by Application (2017-2028)
9.4 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country
9.4.1 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Medicines for Eosinophilic Asthma Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size (2017-2028)
10.2 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method
10.2.1 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method (2017-2022)
10.2.2 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Drug Delivery Method (2023-2028)
10.2.3 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Share by Drug Delivery Method (2017-2028)
10.3 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Application
10.3.1 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country
10.4.1 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Medicines for Eosinophilic Asthma Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Medicines for Eosinophilic Asthma Treatment Introduction
11.1.4 AstraZeneca Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
11.1.5 AstraZeneca Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Medicines for Eosinophilic Asthma Treatment Introduction
11.2.4 GSK Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
11.2.5 GSK Recent Developments
11.3 Genentech (Roche Group) & Novartis
11.3.1 Genentech (Roche Group) & Novartis Company Details
11.3.2 Genentech (Roche Group) & Novartis Business Overview
11.3.3 Genentech (Roche Group) & Novartis Medicines for Eosinophilic Asthma Treatment Introduction
11.3.4 Genentech (Roche Group) & Novartis Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
11.3.5 Genentech (Roche Group) & Novartis Recent Developments
11.4 Regeneron Pharmaceuticals & Sanofi
11.4.1 Regeneron Pharmaceuticals & Sanofi Company Details
11.4.2 Regeneron Pharmaceuticals & Sanofi Business Overview
11.4.3 Regeneron Pharmaceuticals & Sanofi Medicines for Eosinophilic Asthma Treatment Introduction
11.4.4 Regeneron Pharmaceuticals & Sanofi Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
11.4.5 Regeneron Pharmaceuticals & Sanofi Recent Developments
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Medicines for Eosinophilic Asthma Treatment Introduction
11.5.4 Teva Pharmaceuticals Revenue in Medicines for Eosinophilic Asthma Treatment Business (2017-2022)
11.5.5 Teva Pharmaceuticals Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の好酸球性喘息治療薬市場インサイト及び予測（静脈内注入、皮下注射）(Global Medicines for Eosinophilic Asthma Treatment Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 咳喘息（CVA）治療薬の世界市場見通し2023年-2029年
  • 好酸球性喘息治療薬の世界市場見通し2023年-2029年
  • 世界の注射ペプチド薬市場インサイト及び予測（静脈内注射、皮下注射）
  • 世界の経口薄膜薬物送達市場インサイト及び予測（OTC、Rx）
  • 世界の薄膜ドラッグデリバリー市場インサイト及び予測（経口用薄膜、経皮用フィルム、その他）